Macrophage peroxisome proliferator-activated receptor B deficiency delays skin wound healing through impairing apoptotic cell clearance in mice

Cell Death and Disease

Volumn 6, Issue 1, 2015, Pages

  Chen, H ^a   Shi, R ^a   Luo, B ^a   Yang, X ^a   Qiu, L ^a   Xiong, J ^a   Jiang, M ^a   Liu, Y ^a   Zhang, Z ^a   Wu, Y ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MACROPHAGE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; GENOTYPE; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; STAINING; TISSUE REPAIR; UPREGULATION; WOUND HEALING IMPAIRMENT; AGONISTS; ANIMAL; C57BL MOUSE; CELL COUNT; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SKIN; WOUND HEALING;

MUS;

ANIMALS; APOPTOSIS; CELL COUNT; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTOSIS; PPAR GAMMA; RNA, MESSENGER; SKIN; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84927583654     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.544     Document Type: Article

References (63)

1. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RH. Macrophages in skin injury and repair. Immunobiology 2011; 216: 753-762.
2. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007; 25: 9-18.
3. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
4. Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009; 17: 763-771.
5. Natarajan S, Williamson D, Stiltz AJ, Harding K. Advances in wound care and healing technology. Am J Clin Dermatol 2000; 1: 269-275.
6. Martin JM, Zenilman JM, Lazarus GS. Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010; 130: 38-48.
7. Mirza R, DiPietro LA, Koh TJ. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009; 175: 2454-2462.
8. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010; 184: 3964-3977.
9. Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Exp Rev Mol Med 2011; 13: e23.
10. Stout RD. Editorial: macrophage functional phenotypes: no alternatives in dermal wound healing? J Leukoc Biol 2010; 87: 19-21.
11. Wu YS, Chen SN. Apoptotic cell: linkage of inflammation and wound healing. Front Pharmacol 2014; 5: 1.
12. Rodero MP, Khosrotehrani K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol 2010; 3: 643-653.
13. Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PloS One 2010; 5: e9539.
14. Tang Y, Zhang MJ, Hellmann J, Kosuri M, Bhatnagar A, Spite M. Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes 2013; 62: 618-627.
15. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001; 117: 1027-1035.
16. Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 2001; 154: 799-814.
17. Tan NS, Michalik L, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? Am J Clin Dermatol 2003; 4: 523-530.
18. Tan NS, Michalik L, Di-Poi N, Desvergne B, Wahli W. Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing. Biochem Soc Transac 2004; 32: 97-102.
19. Li J, Li P, Zhang Y, Li GB, He FT, Zhou YG et al. Upregulation of ski in fibroblast is implicated in the peroxisome proliferator-activated receptor delta-mediated wound healing. Cell Physiol Biochem 2012; 30: 1059-1071.
20. Rigamonti E, Chinetti-Gbaguidi G, Staels B. Regulation of macrophage functions by PPARalpha, PPAR-gamma, and LXRs in mice and men. Arterioscler Thromb Vasc Biol 2008; 28: 1050-1059.
21. Majai G, Sarang Z, Csomos K, Zahuczky G, Fesus L. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol 2007; 37: 1343-1354.
22. Roszer T, Menendez-Gutierrez MP, Lefterova MI, Alameda D, Nunez V, Lazar MA et al. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol 2011; 186: 621-631.
23. Asada K, Sasaki S, Suda T, Chida K, Nakamura H. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med 2004; 169: 195-200.
24. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116-1120.
25. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ et al. Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol 2001; 159: 457-463.
26. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R et al. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 2003; 13: 1122-1128.
27. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005; 15: 599-607.
28. Peters T, Sindrilaru A, Hinz B, Hinrichs R, Menke A, Al-Azzeh EA et al.Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J 2005; 24: 3400-3410.
29. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007; 170: 1178-1191.
30. Ishida Y, Gao JL, Murphy PM. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008; 180: 569-579.
31. Sindrilaru A, Peters T, Schymeinsky J, Oreshkova T,Wang H, Gompf A et al. Wound healing defect of Vav3-/- mice due to impaired {beta}2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils. Blood 2009; 113: 5266-5276.
32. Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermat 2007; 127: 2645-2655.
33. Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N et al. Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia 2010; 53: 378-388.
34. Lai JJ, Lai KP, Chuang KH, Chang P, Yu IC, Lin WJ et al. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest 2009; 119: 3739-3751.
35. Ashcroft GS, Jeong MJ, Ashworth JJ, Hardman M, Jin W, Moutsopoulos N et al. Tumor necrosis factor-alpha (TNF-alpha) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen 2012; 20: 38-49.
36. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011; 121: 985-997.
37. Xu F, Zhang C, Graves DT. Abnormal cell responses and role of TNF-alpha in impaired diabetic wound healing. BioMed Res Int 2013; 2013: 754802.
38. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870.
39. Weigert A, Jennewein C, Brune B. The liaison between apoptotic cells and macrophages-the end programs the beginning. Biol Chem 2009; 390: 379-390.
40. Hart SP, Smith JR, Dransfield I. Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement. Clin Exp Immunol 2004; 135: 181-185.
41. Kliewer SA, Xu HE, Lambert MH, Willson TM. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 2001; 56: 239-263.
42. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ 2008; 15: 243-250.
43. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011; 12: 1035-1044.
44. Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DWet al. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4. Blood 2009; 113: 2047-2055.
45. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM Jr., Hajjar DP et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 2000; 41: 688-696.
46. McCarty MF, Barroso-Aranda J, Contreras F. PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. Med Hypotheses 2008; 70: 419-423.
47. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009; 31: 245-258.
48. Piraino G, Cook JA, O'Connor M, Hake PW, Burroughs TJ, Teti D et al. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. Shock 2006; 26: 146-153.
49. Salomon GD, Kasid A, Cromack DT, Director E, Talbot TL, Sank A et al. The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg 1991; 214: 175-180.
50. Rapala K, Laato M, Niinikoski J, Kujari H, Soder O, Mauviel A et al. Tumor necrosis factor alpha inhibits wound healing in the rat. Eur Surg Res 1991; 23: 261-268.
51. Jennewein C, Kuhn AM, Schmidt MV, Meilladec-Jullig V, von Knethen A, Gonzalez FJ et al. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J Immunol 2008; 181: 5646-5652.
52. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M et al. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1146-L1153.
53. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol 2009; 174: 519-533.
54. Kapoor M, Kojima F, Yang L, Crofford LJ. Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study. Prostag Leukotr Ess Fatty Acids 2007; 76: 103-112.
55. Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 2007; 117: 1658-1669.
56. Meszaros AJ, Reichner JS, Albina JE. Macrophage phagocytosis of wound neutrophils. J Leukoc Biol 1999; 65: 35-42.
57. Albina JE, Mills CD, Barbul A, Thirkill CE, Henry Jr WL, Mastrofrancesco B et al. Arginine metabolism in wounds. Am J Physiol 1988; 254: E459-E467.
58. Efron DT, Barbul A. Subcutaneous sponge models. Methods Mol Med 2003; 78: 83-93.
59. Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE. The phenotype of murine wound macrophages. J Leukoc Biol 2010; 87: 59-67.
60. Daley JM, Reichner JS, Mahoney EJ, Manfield L, Henry Jr WL, Mastrofrancesco B et al. Modulation of macrophage phenotype by soluble product(s) released from neutrophils. J Immunol 2005; 174: 2265-2272.
61. Schaffer MR, Tantry U, Barbul A. Wound fluid inhibits wound fibroblast nitric oxide synthesis. J Surg Res 2004; 122: 43-48.
62. Roy S, Khanna S, Nallu K, Hunt TK, Sen CK. Dermal wound healing is subject to redox control. Mol Ther 2006; 13: 211-220.
63. Li H, Wang C, Guo G, Gao C, Wu Y, Chen Y. The characteristic expression of B7-associated proteins in Langerhans cell sarcoma. Acta Histochem 2012; 114: 733-743.